Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_38becc8e35e00c04c631134a432356f1 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4458 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 |
filingDate |
2013-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37a302d0ace85155b56d6d0db18e2173 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_067b157204e31d148ba079fc4c56fce2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9074f5a80d4f17ae84d4993ab44a7af6 |
publicationDate |
2014-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2014194524-A1 |
titleOfInvention |
Methods for Treating Alzheimer's Disease |
abstract |
Cognitive impairments in humans with Alzheimer's disease are treated by administering a composition that includes an amphetamine compound. Memory, attention and executive function can be improved following administration of the amphetamine compound. |
priorityDate |
2000-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |